ICON (ICLR) Q1 Earnings Surpass Estimates, Margins Expand
https://www.zacks.com/stock/news/2262670/icon-iclr-q1-earnings-surpass-estimates-margins-expand?cid=CS-ZC-FT-analyst_blog|earnings_article-2262670
Apr 25, 2024 - ICON's (ICLR) first-quarter 2024 performance is driven by its efficient service delivery and strong cost control.
0
Boston Scientific (BSX) Q1 Earnings Beat Estimates, View Raised
https://www.zacks.com/stock/news/2261543/boston-scientific-bsx-q1-earnings-beat-estimates-view-raised?cid=CS-ZC-FT-analyst_blog|earnings_article-2261543
Apr 24, 2024 - Barring Neuromodulation, organic and operational revenues at Boston Scientific's (BSX) core business segments rise in the first quarter.
0
ICON (ICLR) Gains From New Offerings, Strategic Acquisitions
https://www.zacks.com/stock/news/2257821/icon-iclr-gains-from-new-offerings-strategic-acquisitions?cid=CS-ZC-FT-analyst_blog|zer_report_update-2257821
Apr 18, 2024 - ICON (ICLR) continues to develop its collaboration and delivery models, invest in technology and enhance its project and program management capabilities.
0